Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Precancerous Conditions 1Papillomavirus Infections 1Atypical Squamous Cells of the Cervix 1

Interventions

Polymerase Chain Reaction 3Radiotherapy, Intensity-Modulated 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cisplatin 2Cetuximab 2Watchful Waiting 1Vaginal Smears 1Radiotherapy 1Papanicolaou Test 1Paclitaxel 1Mindfulness-Based Stress Reduction 1Light Coagulation 1Histological Techniques 1Gene Expression Profiling 1Folic Acid 1Flow Cytometry 1Early Intervention, Educational 1Comparative Genomic Hybridization 1Colposcopy 1Cidofovir 1Carboplatin 1Brachytherapy 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papillomavirus Infections × Folic Acid × Other neoplasm × Clear all
NCT00703196 2015-10-08

Folic Acid Clinical Trial for the Prevention of Cervical Cancer

University of Alabama at Birmingham

Phase 2 Completed
368 enrolled
GynecologicOther neoplasm

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, Papillomavirus Infections, Atypical Squamous Cells of the Cervix

Data powered by HemOnc (CC BY 4.0) Colophon âš¡